Sign in

CIK 0000886163

  • Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770160744
Phone
+1 858-550-7500
Business address
7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,384,247
in 9 filings, $4.7M under 10b5-1 plans

Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-02-12 Berkman Charles S VP, Gen. Counsel & Secretary Exercise or conversion · Employee Stock Option (right to buy) −386 4,947
2014-02-12 Berkman Charles S VP, Gen. Counsel & Secretary Grant or award · Employee Stock Option (right to buy) +20,000 $74.42 $1.5M 20,000
2014-02-12 Berkman Charles S VP, Gen. Counsel & Secretary Exercise or conversion · Non-Qualified Stock Option (right to buy) −1,736 347
2014-02-12 Berkman Charles S VP, Gen. Counsel & Secretary Exercise or conversion · Non-Qualified Stock Option (right to buy) −4,779 0
2014-02-12 Berkman Charles S VP, Gen. Counsel & Secretary Exercise or conversion · Non-Qualified Stock Option (right to buy) −1,000 0
2014-02-12 Berkman Charles S VP, Gen. Counsel & Secretary Exercise or conversion · Non-Qualified Stock Option (right to buy) −1,166 0
2014-02-12 Berkman Charles S VP, Gen. Counsel & Secretary Exercise or conversion · Non-Qualified Stock Option (right to buy) −4,584 10,560
2014-02-12 HIGGINS JOHN L President & CEO Exercise or conversion +16,875 $9.96 $168K 127,974
2014-02-12 HIGGINS JOHN L President & CEO Sale −16,875 $75.00 $1.3M 111,099
2014-02-12 HIGGINS JOHN L President & CEO Grant or award +8,000 119,099
2014-02-12 HIGGINS JOHN L President & CEO Grant or award · Employee Stock Option (right to buy) +75,000 $74.42 $5.6M 75,000
2014-02-12 HIGGINS JOHN L President & CEO Grant or award · Employee Stock Option (right to buy) +10,000 $74.42 $744K 85,000
2014-02-12 HIGGINS JOHN L President & CEO Grant or award · Employee Stock Option (right to buy) +10,000 $74.42 $744K 95,000
2014-02-12 HIGGINS JOHN L President & CEO Exercise or conversion · Non-Qualified Stock Option (right to buy) −16,875 48,125
2014-02-12 FOEHR MATTHEW W EVP and COO Grant or award +5,000 50,013
2014-02-12 FOEHR MATTHEW W EVP and COO Grant or award · Employee Stock Option (right to buy) +45,000 $74.42 $3.3M 45,000
2014-02-12 FOEHR MATTHEW W EVP and COO Grant or award · Employee Stock Option (right to buy) +10,000 $74.42 $744K 55,000
2014-02-12 FOEHR MATTHEW W EVP and COO Grant or award · Employee Stock Option (right to buy) +10,000 $74.42 $744K 65,000
2014-02-12 DeSilva Nishan M VP, Corporate Development Grant or award +3,000 18,659
2014-02-12 DeSilva Nishan M VP, Corporate Development Grant or award · Employee Stock Option (right to buy) +35,000 $74.42 $2.6M 35,000

Page 79 of 86 · 1,712 trades